GGrantIndex
← Leaderboards

Organix, Inc.

Woburn, MA

Compare ↔
$15,838,979
Total funding
18
Grants

Funding over time

peak $2M · FY2005–18
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18

Funding mix

By agency

NIH$15,838,979 · 18

By mechanism

R01$7,945,971 · 3
R44$4,124,271 · 3
R43$2,827,579 · 8
R03$710,673 · 2
N01$230,485 · 1
P01$0 · 1

Investigators at Organix, Inc.

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

Not enough data

All-Time

Most funded here, all years

1Anuradha Mahadevan$4,850,5507 gr2Howard P Sard$3,742,8435 gr3Peter C Meltzer$2,781,9752 gr4Vishnumurthy R Hegde$207,9551 gr

Largest grants

Targeting Breast Cancer Metastasis with Id1$809,827
R44 · FY2017 · CA
Targeting Breast Cancer Metastasis with Id1$743,502
R44 · FY2018 · CA
Indole Analogs as Novel Treatments for OCD$515,877
R44 · FY2006 · MH
Indole Analogs as Novel Treatments for OCD$479,436
R44 · FY2008 · MH
Indole Analogs as Novel Treatments for OCD$469,609
R44 · FY2007 · MH
Indole Analogs as Novel Appetite Suppressants$436,879
R44 · FY2007 · DK
Discovery of Novel Pharmacotherapies: Cocaine Dependence$435,000
R01 · FY2004 · DA
Discovery of Novel Pharmacotherapies: Cocaine Dependence$408,750
R01 · FY2005 · DA
Discovery of Novel Pharmacotherapies: Cocaine Dependence$399,144
R01 · FY2006 · DA
Indole Analogs as Novel Appetite Suppressants$394,714
R44 · FY2008 · DK
Discovery of Novel Pharmacotherapies: Cocaine Dependence$387,569
R01 · FY2007 · DA
Discovery of Novel Pharmacotherapies: Cocaine Dependence$379,817
R01 · FY2008 · DA
Delta9-Tetrahydrocannabinol Related Compounds$358,750
R01 · FY2005 · DA
Synthesis of delta9-Tetrahydrocannabinol Related Compounds$358,750
R01 · FY2007 · DA
Delta9-Tetrahydrocannabinol Related Compounds$358,750
R01 · FY2002 · DA
Delta9-Tetrahydrocannabinol Related Compounds$358,750
R01 · FY2003 · DA
Delta9-Tetrahydrocannabinol Related Compounds$358,750
R01 · FY2004 · DA
Synthesis of delta9-Tetrahydrocannabinol Related Compounds$351,575
R01 · FY2008 · DA
Synthesis of delta9-Tetrahydrocannabinol Related Compounds$351,575
R01 · FY2009 · DA
Delta9-Tetrahydrocannabinol Related Compounds$350,320
R01 · FY2006 · DA